Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Longterm timolol therapy.

L L Lin, M A Galin, S A Obstbaum

    Survey of Ophthalmology
    |May 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Topical timolol significantly reduced intraocular pressure in glaucoma patients by decreasing aqueous secretion. The addition of epinephrine further enhanced pressure control in this study.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    AI based sentiment analysis of online discussions related to cervical brachytherapy.

    Technical innovations & patient support in radiation oncology·2025
    Same author

    [Dehydrated hereditary stomatocytosis in 23 cases: a single-center retrospective cohort study from Peking Union Medical College Hospital (2018-2024)].

    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2025
    Same author

    [The 509th case: fatigue, sleepiness, mood disorder, and hypothyroidism].

    Zhonghua nei ke za zhi·2024
    Same author

    [Untargeted metabolomics study of dexamethasone-induced congenital cleft palate in New Zealand rabbits].

    Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology·2023
    Same author

    The impact of bedside wipes in multi-patient rooms: a prospective, crossover trial evaluating infections and survival.

    The Journal of hospital infection·2023
    Same author

    [The study of mitochondrial disorder pedigree associated with FASTKD2 variants and uniparental disomy].

    Zhonghua yi xue za zhi·2023
    Same journal

    Trends in pediatric uveitis: A systematic review and meta-epidemiological investigation of geographic, economic, and climate factors.

    Survey of ophthalmology·2026
    Same journal

    Efficacy and safety of different intraocular therapies for non-infectious uveitis: A network meta-analysis.

    Survey of ophthalmology·2026
    Same journal

    Macular telangiectasia masqueraders.

    Survey of ophthalmology·2026
    Same journal

    Utilization of anterior segment optical coherence tomography in childhood glaucoma: A systematic review.

    Survey of ophthalmology·2026
    Same journal

    Peripapillary pachychoroid syndrome: Clinical and imaging features, diagnostic differentiation and therapeutic strategies.

    Survey of ophthalmology·2026
    Same journal

    Prognostic factors and postoperative outcomes in pediatric cataract patients: A systematic review and meta-analysis.

    Survey of ophthalmology·2026
    See all related articles

    Area of Science:

    • Ophthalmology
    • Pharmacology

    Background:

    • Elevated intraocular pressure (IOP) is a primary risk factor for glaucoma.
    • Timolol is a beta-blocker commonly used in ophthalmic preparations.

    Purpose of the Study:

    • To evaluate the efficacy of topical timolol in reducing intraocular pressure.
    • To investigate the mechanism of IOP reduction and the effect of combination therapy.

    Main Methods:

    • A study involving 118 patients with ocular hypertension or glaucoma.
    • Twice-daily topical instillation of 0.25% or 0.5% timolol.
    • Measurement of intraocular pressure, outflow facility, and aqueous secretion.

    Main Results:

    • Timolol significantly reduced intraocular pressure in all patient groups.

    Related Experiment Videos

  • Reduced aqueous secretion was the primary mechanism for IOP reduction.
  • Timolol monotherapy controlled IOP in 68-87% of patients.
  • Combination therapy with epinephrine achieved IOP below 22 mm Hg in 85% of patients.

    • Conclusions:

    • Topical timolol is effective in lowering intraocular pressure.
    • The primary mechanism of action is the reduction of aqueous humor secretion.
    • Combination therapy with epinephrine offers enhanced IOP control for glaucoma patients.